Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WJ-MSC Exosomes in Diabetic Foot Ulcers
NCT06812637Phase 1Completed
- Sponsor
- Kafrelsheikh University
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of extracellular vesicles derived from Wharton's jelly mesenchymal stem cells in diabetic foot ulcer (DFU) (3 arms), sponsored by Kafrelsheikh University. Primary endpoint: Ulcer healing at 20 weeks. Started Apr 2024; status: completed.
02
Drugs
extracellular vesicles derived from Wharton's jelly mesenchymal stem cells
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06812637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06812637.